Published in Diabetes on April 01, 1986
Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF. J Clin Invest (2002) 1.95
Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor. Proc Natl Acad Sci U S A (2001) 1.83
IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development. Proc Natl Acad Sci U S A (2007) 1.77
Regulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis. J Biol Chem (2009) 1.68
Evidence that upregulation of serum IGF-1 concentration can trigger acceleration of diabetic retinopathy. Br J Ophthalmol (1998) 1.62
Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects. J Clin Invest (1993) 1.35
Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy. Br J Ophthalmol (1996) 1.29
Increased ocular levels of IGF-1 in transgenic mice lead to diabetes-like eye disease. J Clin Invest (2004) 1.16
The biochemistry of diabetes. Biochem J (1988) 1.14
Involvement of protein kinase CK2 in angiogenesis and retinal neovascularization. Invest Ophthalmol Vis Sci (2004) 1.06
Human growth hormone stimulates proliferation of human retinal microvascular endothelial cells in vitro. Proc Natl Acad Sci U S A (1991) 0.93
Increased intraocular insulin-like growth factor-I triggers blood-retinal barrier breakdown. J Biol Chem (2009) 0.90
Long-term retinal PEDF overexpression prevents neovascularization in a murine adult model of retinopathy. PLoS One (2012) 0.90
Serum insulin-like growth factor-I in diabetic retinopathy. Mol Vis (2011) 0.89
Retinal and preretinal localisation of epidermal growth factor, transforming growth factor alpha, and their receptor in proliferative diabetic retinopathy. Br J Ophthalmol (1994) 0.89
Biological activities of vitreous gel, retrohyaloid fluid and subretinal fluid from diabetic and non-diabetic eyes. Br J Ophthalmol (1992) 0.84
Transplantation of Human Neural Progenitor Cells Expressing IGF-1 Enhances Retinal Ganglion Cell Survival. PLoS One (2015) 0.83
Characterization of release of basic fibroblast growth factor from bovine retinal endothelial cells in monolayer cultures. Biochem J (1991) 0.82
Vitreous IGFBP-3 effects on Müller cell proliferation and tractional force generation. Invest Ophthalmol Vis Sci (2012) 0.81
Production of IGF-I and IGF binding proteins by retinal cells in vitro. Br J Ophthalmol (1994) 0.80
Isolation and characterization of vitreous insulin-like growth factor binding proteins. Invest Ophthalmol Vis Sci (2011) 0.80
An ocular view of the IGF-IGFBP system. Growth Horm IGF Res (2013) 0.78
Proliferative diabetic retinopathy in acromegaly. Oman J Ophthalmol (2010) 0.78
A chronic grey matter penumbra, lateral microvascular intussusception and venous peduncular avulsion underlie diabetic vitreous haemorrhage. Br J Ophthalmol (2007) 0.78
Protein kinase B (akt) promotes pathological angiogenesis in murine model of oxygen-induced retinopathy. Acta Histochem Cytochem (2011) 0.77
Current management of vitreous hemorrhage due to proliferative diabetic retinopathy. Int Ophthalmol Clin (2014) 0.76
Association Between Diabetic Macular Edema and Cardiovascular Events in Type 2 Diabetes Patients: A Multicenter Observational Study. Medicine (Baltimore) (2015) 0.75
Proliferative retinopathy with growth hormone deficiency and diabetes mellitus. BMJ (1990) 0.75
Promoting vascular repair in the retina: can stem/progenitor cells help? Eye Brain (2016) 0.75
Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction (1993) 41.55
The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75
Rapid pulsed-field gel electrophoresis protocol for subtyping of Campylobacter jejuni. J Clin Microbiol (2001) 3.81
Use of a HpaII-polymerase chain reaction assay to study DNA methylation in the Pgk-1 CpG island of mouse embryos at the time of X-chromosome inactivation. Mol Cell Biol (1990) 3.78
Measurement of the quality of life in cancer survivors. Qual Life Res (1995) 3.51
Alcohol consumption and related problems among primary health care patients: WHO collaborative project on early detection of persons with harmful alcohol consumption--I. Addiction (1993) 2.83
Salt accumulation and adenosine triphosphate in carrot xylem tissue. Proc Natl Acad Sci U S A (1966) 2.55
Salmonellosis epidermic related to a caterer-delicatessen-restaurant. Am J Public Health Nations Health (1968) 2.43
Patterns of Guillain-Barre syndrome in children: results from a Mexican population. Neurology (2007) 2.32
Comparison of PFGE, ribotyping and phage-typing in the epidemiological analysis of Campylobacter jejuni serotype HS2 infections. Epidemiol Infect (1995) 2.30
Molecular subtyping scheme for serotypes HS1 and HS4 of Campylobacter jejuni. J Clin Microbiol (1995) 2.01
An outbreak of Campylobacter jejuni infections associated with food handler contamination: the use of pulsed-field gel electrophoresis. J Infect Dis (2000) 1.99
Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivax. J Infect Dis (2008) 1.96
Human T-cell leukemia virus type 1 Tax induction of NF-kappaB involves activation of the IkappaB kinase alpha (IKKalpha) and IKKbeta cellular kinases. Mol Cell Biol (1998) 1.79
Expression of insulin growth factor-1 splice variants and structural genes in rabbit skeletal muscle induced by stretch and stimulation. J Physiol (1999) 1.74
In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax. Antimicrob Agents Chemother (2010) 1.70
Flagellin gene polymorphism analysis of Campylobacter jejuni infecting man and other hosts and comparison with biotyping and somatic antigen serotyping. Epidemiol Infect (1994) 1.68
Effect of arginine on serum-levels of human growth-hormone. Lancet (1965) 1.65
Genetic aspects of clinical endocrinology. Recent Prog Horm Res (1968) 1.64
Prevalence of conception and pregnancy outcomes after hematopoietic cell transplantation: report from the Bone Marrow Transplant Survivor Study. Bone Marrow Transplant (2006) 1.63
Health aides add new dimension to home care program. Hospitals (1966) 1.59
Insulin-like growth factors in pygmies. The role of puberty in determining final stature. N Engl J Med (1987) 1.55
Plant responses to potassium deficiencies: a role for potassium transport proteins. J Exp Bot (2005) 1.55
The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled study. Diabetes Care (2000) 1.54
Demographic and therapeutic determinants of pain reactivity in very low birth weight neonates at 32 Weeks' postconceptional Age. Pediatrics (2001) 1.52
Growth-hormone deficiency in man: an isolated, recessively inherited defect. Science (1966) 1.51
Domain swapping and gene shuffling identify sequences required for induction of an Avr-dependent hypersensitive response by the tomato Cf-4 and Cf-9 proteins. Plant Cell (2001) 1.50
A cross sectional study of 100 athletes with jumper's knee managed conservatively and surgically. The Victorian Institute of Sport Tendon Study Group. Br J Sports Med (1997) 1.41
Solidification of a supercooled liquid in a narrow channel. Phys Rev Lett (2001) 1.40
Insulin-like growth factors. Studies in diabetics with and without retinopathy. N Engl J Med (1983) 1.38
An oral history of changes in the Australian diet. Med J Aust (1993) 1.38
HIV and idiotypic T-cell regulation. Immunol Today (1991) 1.38
Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries. Circulation (1986) 1.35
Patterns of hormonal release after glucose, protein, and glucose plus protein. Lancet (1966) 1.31
Growth hormone and insulin release after arginine: indifference to hyperglycemia and epinephrine. J Clin Endocrinol Metab (1966) 1.27
A public health program for sexually assaulted females. Public Health Rep (1967) 1.27
Stronger activity of human immunodeficiency virus type 1 protease inhibitors against clinical isolates of Plasmodium vivax than against those of P. falciparum. Antimicrob Agents Chemother (2008) 1.26
Iliad training enhances medical students' diagnostic skills. J Med Syst (1991) 1.25
The impact of cancer pain education on family caregivers of elderly patients. Oncol Nurs Forum (1995) 1.24
An institutional commitment to pain management. J Clin Oncol (1995) 1.23
Fabrication of microtextured membranes for cardiac myocyte attachment and orientation. J Biomed Mater Res (2000) 1.21
AtBI-1, a plant homologue of Bax inhibitor-1, suppresses Bax-induced cell death in yeast and is rapidly upregulated during wounding and pathogen challenge. Plant J (2000) 1.20
Sequence polymorphisms in pfcrt are strongly associated with chloroquine resistance in Plasmodium falciparum. J Infect Dis (2001) 1.20
Sexual assault on women and children in the District of Columbia. Public Health Rep (1968) 1.18
The effects of a double blind, placebo controlled, artificial food colourings and benzoate preservative challenge on hyperactivity in a general population sample of preschool children. Arch Dis Child (2004) 1.18
A metabolic and hormonal basis for classifying ateliotic dwarfs. Lancet (1969) 1.17
Arginine-initiated release of human growth hormone. Factors modifying the response in normal man. N Engl J Med (1969) 1.17
Common source outbreaks of Campylobacter infection in the USA, 1997-2008. Epidemiol Infect (2012) 1.17
Family caregiving in cancer pain management. J Palliat Med (1999) 1.15
Autosomal dominant (Beukes) premature degenerative osteoarthropathy of the hip joint maps to an 11-cM region on chromosome 4q35. Am J Hum Genet (1999) 1.14
Studies of the sex based variation of human growth hormone secretion. J Clin Endocrinol Metab (1971) 1.14
Renal epithelial fluid secretion and cyst growth: the role of cyclic AMP. FASEB J (1989) 1.13
Dwarfism in the pygmy. An isolated deficiency of insulin-like growth factor I. N Engl J Med (1981) 1.13
Utilization of a basic care and prevention package by HIV-infected persons in Uganda. AIDS Care (2008) 1.11
Plasma growth hormone after arginine infusion. Clinical experiences. N Engl J Med (1967) 1.11
Peripheral subresponsiveness to human growth hormone in the African pygmies. N Engl J Med (1969) 1.11
Genomic and functional analyses of Rhodococcus equi phages ReqiPepy6, ReqiPoco6, ReqiPine5, and ReqiDocB7. Appl Environ Microbiol (2010) 1.09
Insulin removal by isolated perfused rat liver. Am J Physiol (1976) 1.08
Insulin-like growth factors in the fed and fasted states. J Clin Endocrinol Metab (1982) 1.08
The meaning of quality of life for bone marrow transplant survivors. Part 1. The impact of bone marrow transplant on quality of life. Cancer Nurs (1992) 1.08
Thermal effects on atomic friction. Phys Rev Lett (2001) 1.08
A randomized outcome evaluation of group exercise programs in long-term care institutions. J Gerontol A Biol Sci Med Sci (1999) 1.07
Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists. Circ Res (1986) 1.07
Myostatin and insulin-like growth factor-I and -II expression in the muscle of rats exposed to the microgravity environment of the NeuroLab space shuttle flight. J Endocrinol (2000) 1.07
Re: "the fate of syndesmotic screws". Foot Ankle Int (2013) 1.06
Quality of life in breast cancer. Part II: Psychological and spiritual well-being. Cancer Nurs (1998) 1.05
Quality of life in breast cancer. Cancer Pract (1997) 1.05
Isolated human growth hormone deficiency. 3. Insulin secretion in sexual ateliotic dwarfism. Metabolism (1968) 1.05
Risk preference and decision making in critical care situations. Chest (1988) 1.04
Multilayer vascular grafts based on collagen-mimetic proteins. Acta Biomater (2011) 1.03
Insulin-like growth factor I acts as an angiogenic agent in rabbit cornea and retina: comparative studies with basic fibroblast growth factor. Diabetologia (1993) 1.03
Glycosylated serum protein and hemoglobin A1 levels to measure control of glycemia. Ann Intern Med (1981) 1.03
Metabolic studies in the African pygmy. Trans Assoc Am Physicians (1968) 1.03
Stabilization of plasma glucose during fasting; Normal variations in two separate studies. N Engl J Med (1974) 1.03
In vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquine-resistant Plasmodium vivax. Antimicrob Agents Chemother (2008) 1.03
Analysis of pain content in nursing textbooks. J Pain Symptom Manage (2000) 1.02
Bioactive hydrogels based on Designer Collagens. Acta Biomater (2010) 1.02
Competition alters the perception of noxious stimuli in male and female athletes. Pain (1998) 1.02
A six country survey of the content and structure of heroin treatment programmes using methadone. Br J Addict (1991) 1.02
A follow-up study of vascular disease in growth-hormone-deficient dwarfs with diabetes. N Engl J Med (1978) 1.02
Screening for sexually transmitted diseases and hepatitis in 18-29-year-old men recently released from prison: feasibility and acceptability. Int J STD AIDS (2005) 1.02
In vivo and in vitro efficacy of chloroquine against Plasmodium malariae and P. ovale in Papua, Indonesia. Antimicrob Agents Chemother (2010) 1.02
Uncertainty in illness theory: a replication of the mediating effects of mastery and coping. Nurs Res (1991) 1.02
The pain resource nurse training program: a unique approach to pain management. J Pain Symptom Manage (1993) 1.01
Effects of cognitive coping skills training on coping strategies and experimental pain sensitivity in African American adults with sickle cell disease. Health Psychol (1996) 1.01
The experience of pain and perceptions of quality of life: validation of a conceptual model. Hosp J (1991) 0.99
Histologic analysis of needle biopsy of urethral sphincter from women with normal and stress incontinence with comparison of electromyographic findings. Am J Obstet Gynecol (1999) 0.99
Pain as a metaphor for illness. Part I: Impact of cancer pain on family caregivers. Oncol Nurs Forum (1992) 0.99
c-Src is required for stimulation of gelsolin-associated phosphatidylinositol 3-kinase. J Biol Chem (1998) 0.99
The effervescent gallbladder: a sonographic sign of emphysematous cholecystitis. AJR Am J Roentgenol (1988) 0.99
Insulin-like growth factor-II in nonislet cell tumors associated with hypoglycemia: increased levels of messenger ribonucleic acid. J Clin Endocrinol Metab (1989) 0.98
Biobehavioral pain responses in former extremely low birth weight infants at four months' corrected age. Pediatrics (2000) 0.98
Sarcoidosis Treated with Calciferol. Proc R Soc Med (1946) 0.97
Pain management at home. Struggle, comfort, and mission. Cancer Nurs (1993) 0.96
Survey of the provision of supportive care services at National Cancer Institute-designated cancer centers. J Clin Oncol (1995) 0.96
Metabolic effects of human growth hormone in the African pygmy. Lancet (1968) 0.96
Molecular forms of serum insulin-like growth factor (IGF)-binding proteins in man: relationships with growth hormone and IGFs and physiological significance. J Clin Endocrinol Metab (1989) 0.96
A randomized clinical trial of brief interventions in primary care: summary of a WHO project. Addiction (1994) 0.96
Analysis of livelihood security: a case study in the Kali-Khola watershed of Nepal. J Environ Manage (2006) 0.95
The role of macrophage-derived chemoattractant activities in the early inflammatory events of bleomycin-induced pulmonary injury. Am Rev Respir Dis (1983) 0.95